Multiple Manufacturers



Multiple Manufacturers

Humalog HCPCS:


HCPCS Code Descriptor:

Insulin for administration through dme (i.e., insulin pump) per 50 units


J Code

Humalog NDCs:

00002-8501-01, 00002-8501-01, 00169-6339-10, 00169-2201-25, 00169-2101-25, 00169-3303-12, 00002-8799-59, 00002-8213-05, 00002-7516-59, 00169-2200-11, 00169-7501-11, 00169-2100-11, 00002-7510-01, 00002-7752-05, 00002-8222-59, 00002-7510-17, 00002-7737-01, 66733-0773-01

Primary Type:


Generic/Specialty Status:


Route of Administration:


Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00002-7510-17, 66733-0773-01

About Humalog:

Humalog is an Insulin drug manufactured by Eli Lilly and Company and administered via the Subcutaneous route of administration. The J Code: J1817 is aligned to the drug Humalog.

Humalog is a type of insulin injection that may be used to improve control over blood sugar levels in children and adults with diabetes mellitus. It may also be used to treat type 2 diabetes in adults, and type 1 diabetes in both adults and children. Humalog is a fast-acting type of insulin and has been shown to begin working in about 15 minutes. Humalog typically peaks about one hour after injection and may continue working for two to four hours. Humalog is thought to work by lowering and controlling levels of glucose in the blood.


J1817 Added Date:

January 1, 2003

J1817 Effective Date:

January 1, 2003

J1817 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Humalog billing and coding information.
Humalog patient assistance information can be found through the Lilly Cares Foundation at the URL:
Humalog prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for Humalog. Please check back in a few weeks.